Carna Biosciences, Inc. (TYO:4572)
Japan flag Japan · Delayed Price · Currency is JPY
310.00
-7.00 (-2.21%)
Nov 18, 2026, 10:13 AM JST

Carna Biosciences Revenue

Carna Biosciences had revenue of 172.00M JPY in the quarter ending September 30, 2026, with 19.17% growth. This brings the company's total for the last twelve months to 756.57M, up 38.96% year-over-year. In the year 2025, Carna Biosciences had annual revenue of 579.00M, down -8.96%. That makes Carna Biosciences the 40,184th largest company in the world by revenue and 3,814th in Japan.

Revenue (ttm)
756.57M
Revenue Growth
+38.96%
P/S Ratio
9.71
Revenue / Employee
12.40M
Employees
61
Market Cap
7.25B

Revenue Chart

Revenue by Geography

  • United States of America 259.61M 44.8%
  • Japan 169.19M 29.2%
  • China 96.55M 16.7%
  • Europe 47.71M 8.2%
  • Others 5.99M 1.0%
Fiscal year ended Dec 31, 2025 See the full Carna Biosciences breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025579.00M-57.00M-8.96%
Dec 31, 2024636.00M-989.00M-60.86%
Dec 31, 20231.63B239.00M17.24%
Dec 31, 20221.39B-631.00M-31.28%
Dec 31, 20212.02B884.00M78.02%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.